(Q38232377)

31 August 2017

Photodynamic therapy in the esophagus (English)

1 reference

31 August 2017

Shou-Jiang Tang

1

1 reference

PubMed ID

25048066

31 August 2017

Norman E Marcon

series ordinal

2

1 reference

31 August 2017

1 May 2004

1 reference

Photodiagnosis and Photodynamic Therapy

31 August 2017

1 reference

31 August 2017

1

1 reference

31 August 2017

1

1 reference

31 August 2017

65-74

1 reference

Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Palliation of esophageal malignancy with photoradiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for Barrett's esophagus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Balloon photodynamic therapy of esophageal cancer: effect of increasing balloon size

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Optimization of the diameter of a radial irradiation device for photodynamic therapy in the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

New 5-aminolevulinic acid esters--efficient protoporphyrin precursors for photodetection and photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA)

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

EVALUATION OF NEW BENZOPORPHYRIN DERIVATIVES WITH ENHANCED PDT EFFICACY*

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Light dosimetry for photodynamic therapy in the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Comparative study between pulsed and continuous wave lasers for Photofrin photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for Barrett's esophagus: cardiac effects

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Esophageal dysmotility in patients undergoing photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Role of photodynamic therapy in the management of advanced esophageal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for tumor ingrowth through an expandable esophageal stent

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Long-term survival after photodynamic therapy for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastro-esophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Acid suppression and reepithelialization after ablation of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Significance of genetic abnormalities after photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900010-9

7 January 2021

10.1016/S1572-1000(04)00010-9

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

25048066